Latest News & Features
Americas
Labrador Diagnostics has dropped its controversial patent complaint against COVID-19 test developer BioMerieux. 30 June 2020
article
On May 12, 2020, the United Nations Technology Bank, together with the UN Development Programme, UN Conference on Trade and Development and the World Health Organization, launched the Tech Access Partnership as part of a coordinated approach to strengthen developing countries’ responses to COVID-19 and increase access to lifesaving health technologies. 30 June 2020
Americas
Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”. 29 June 2020
Big Pharma
The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be. 26 June 2020
Big Pharma
The English Court of Appeal has rejected Neurim’s attempt to block sales of a generic version of its insomnia drug made by Mylan ahead of a patent infringement trial. 26 June 2020
Americas
Latham & Watkins has added two life sciences-focused litigators, Arlene Chow and Ernest Yakob, to its New York office. 25 June 2020
Americas
Gilead Sciences has begun a potential takeover of Pionyr Immunotherapeutics after it agreed to pay $275 million for a 49.9% equity stake in the cancer research company. 25 June 2020
article
In this unmissable keynote address, Charles will set out the work of the Medicines Patent Pool; How it works and what's proposed around COVID-19. Charles will seek to dispel some of the misinformation around licensing and explain how the MPP will serve to ensure a balance between the need to protect innovation and the need to fight a pandemic. 25 June 2020
Biotechnology
The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice. 24 June 2020
Americas
3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic. 23 June 2020